Abnormal osteoblastic signaling via b-catenenin [23,331], Notch-Jagged1 [20], and osteopontin (OPN) [33] has been proposed to be involved in MDS/AML pathogenesis. The gene discussed is SPP1; the disease is myelodysplastic syndrome.